Mathilde Ducloie

3PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 30, 2025
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Dinu Stefan, Paul Lesueur, Justine Lequesne

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Sep 28, 2024
Contribution of [<sup>18</sup>F]FET PET in the Management of Gliomas, from Diagnosis to Follow-Up: A Review.

Jade Apolline Robert, Arthur Leclerc, Mathilde Ducloie

Pageof 1